Equity Implications of Including Environmental Impacts of Health Technologies in Economic Evaluations Informing Pricing and Reimbursement Decisions

Author(s)

Ardito V1, Banks H2, Tarricone R3
1SDA Bocconi School of Management, MILAN, MI, Italy, 2SDA Bocconi School of Management, Milan, MI, Italy, 3Department of Social and Political Science, Bocconi University, Milano, Italy

OBJECTIVES: Broadening the dimensions of value in healthcare by incorporating further value elements in established cost-effectiveness analysis (CEA) is a topic of discussion. An important factor to consider are environmental costs, namely the impacts on the environment resulting from a health products’ development, production, distribution, use, and disposal. However, including this dimension in CEAs would have equity implications and distributional consequences. The objective of this work is to explore the perception of multiple stakeholders on this issue.

METHODS: As part of the Horizon Europe project HI-PRIX (Grant Agreement: 101095593), semi-structured interviews were conducted. An interview template was developed, pilot tested, and ethically approved. The interviewees were purposely selected to represent different geographies and perspectives. The interviews were conducted online and lasted 45 minutes. All the interviews were recorded and transcribed.

RESULTS: Overall, 17 stakeholders were contacted, and 13 agreed to be interviewed. The interviewees represented seven countries (Belgium, France, Ireland, Netherlands, Portugal, Spain, United Kingdom) and various roles in stakeholder organizations, divided into payers (national HTA and/or regulatory bodies, hospital-based HTA), academics, and industry. In general, interviews showed uncertainty whether CEAs are the right place to start incorporating environmental impact due, e.g., to unresolved methodological challenges and incomplete data. This would require a shift from a health system to a societal perspective for most HTA agencies. Furthermore, correct attribution of environmental costs is a primary concern to industry.

CONCLUSIONS: In principle, the environmental impact of health technologies can be used to widen the evidence base for pricing and reimbursement decisions. However, while “environment” has become a mantra of the modern era, with a variety of stakeholders demanding concrete actions to protect the environment, for the time being, procurement (using rewards and/or penalties) may be a more direct route to encouraging more ecologically responsible decisions on what to allow or finance.

Conference/Value in Health Info

2024-11, ISPOR Europe 2024, Barcelona, Spain

Value in Health, Volume 27, Issue 12, S2 (December 2024)

Code

EE164

Topic

Economic Evaluation, Health Technology Assessment

Topic Subcategory

Decision & Deliberative Processes, Novel & Social Elements of Value

Disease

No Additional Disease & Conditions/Specialized Treatment Areas

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×